Sodium-glucose co-transporter 2 inhibitors and the risk of fractures: A propensity score-matched cohort study.
Sruthi AdimadhyamTodd A LeeGregory Sampang CalipDaphne E Smith MarshBrian T LaydenGlen T SchumockPublished in: Pharmacoepidemiology and drug safety (2019)
There is a possible increase in risk for fractures early in therapy with SGLT2i. Beyond this initial period, SGLT2is had no apparent effect on the incidence of fractures.